A well-established skincare products and treatment company, FAB Group, which runs the Caci clinics, is looking to strengthen and expand ahead of a likely sharemarket listing.
The group, which is franchise based, wants to list on the local stock exchange by 2019 and is reforming its governance and business structures, as well as eyeing overseas opportunities.
The newly-appointed chair Franceska Banga, who stepped down as chief executive of the New Zealand Venture Investment Fund in March, said the company needed to establish itself with investors before listing.
"We want to give future investors confidence and we want to be able to take them for a journey as the company grows over the next two to three years, so there's confidence and the business is well understood."
The group is planning another 13 Caci clinics over the next couple of years to take its network to 50. Revenue for the coming year, including that of franchises, has been forecast at $38 million.
The company has a diversity issue with a difference, the founder, managing director, chair of the board, and the majority of the directors are women.